US20200324034A1 - Dual lumen sheath for arterial access - Google Patents
Dual lumen sheath for arterial access Download PDFInfo
- Publication number
- US20200324034A1 US20200324034A1 US16/907,533 US202016907533A US2020324034A1 US 20200324034 A1 US20200324034 A1 US 20200324034A1 US 202016907533 A US202016907533 A US 202016907533A US 2020324034 A1 US2020324034 A1 US 2020324034A1
- Authority
- US
- United States
- Prior art keywords
- lumen
- sheath
- guidewire
- percutaneous
- stylet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000009977 dual effect Effects 0.000 title description 36
- 238000003780 insertion Methods 0.000 claims abstract description 77
- 230000037431 insertion Effects 0.000 claims abstract description 77
- 210000004204 blood vessel Anatomy 0.000 claims abstract description 56
- 238000000034 method Methods 0.000 claims description 50
- 230000004872 arterial blood pressure Effects 0.000 claims description 18
- 238000009530 blood pressure measurement Methods 0.000 claims description 17
- 230000035602 clotting Effects 0.000 claims description 15
- 239000012530 fluid Substances 0.000 claims description 10
- 238000011010 flushing procedure Methods 0.000 claims description 4
- 230000002463 transducing effect Effects 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 claims description 2
- 238000010926 purge Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 description 29
- 210000004369 blood Anatomy 0.000 description 29
- 230000000087 stabilizing effect Effects 0.000 description 21
- 230000002792 vascular Effects 0.000 description 12
- 239000011248 coating agent Substances 0.000 description 11
- 238000000576 coating method Methods 0.000 description 11
- 238000005259 measurement Methods 0.000 description 10
- 208000032843 Hemorrhage Diseases 0.000 description 8
- 208000034158 bleeding Diseases 0.000 description 8
- 230000000740 bleeding effect Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000004891 communication Methods 0.000 description 7
- 210000001105 femoral artery Anatomy 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 230000000747 cardiac effect Effects 0.000 description 4
- 206010000891 acute myocardial infarction Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 210000005240 left ventricle Anatomy 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000013146 percutaneous coronary intervention Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 208000006117 ST-elevation myocardial infarction Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940030602 cardiac therapy drug Drugs 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Images
Classifications
-
- A61M1/125—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0102—Insertion or introduction using an inner stiffening member, e.g. stylet or push-rod
-
- A61M1/1024—
-
- A61M1/122—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0097—Catheters; Hollow probes characterised by the hub
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M25/09041—Mechanisms for insertion of guide wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/13—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel by means of a catheter allowing explantation, e.g. catheter pumps temporarily introduced via the vascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/135—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel inside a blood vessel, e.g. using grafting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/148—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/205—Non-positive displacement blood pumps
- A61M60/216—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/403—Details relating to driving for non-positive displacement blood pumps
- A61M60/422—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being electromagnetic, e.g. using canned motor pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/865—Devices for guiding or inserting pumps or pumping devices into the patient's body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0001—Catheters; Hollow probes for pressure measurement
- A61M2025/0003—Catheters; Hollow probes for pressure measurement having an additional lumen transmitting fluid pressure to the outside for measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0008—Catheters; Hollow probes having visible markings on its surface, i.e. visible to the naked eye, for any purpose, e.g. insertion depth markers, rotational markers or identification of type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0018—Catheters; Hollow probes having a plug, e.g. an inflatable plug for closing catheter lumens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
- A61M2025/0046—Coatings for improving slidability
- A61M2025/0047—Coatings for improving slidability the inner layer having a higher lubricity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M2025/0286—Holding devices, e.g. on the body anchored in the skin by suture or other skin penetrating devices
Definitions
- a blood pump such as a percutaneous intracardiac blood pump assembly, is introduced in the heart to deliver blood from the heart into an artery.
- a blood pump assembly pulls blood from the left ventricle of the heart and expels blood into the aorta, or pulls blood from the right ventricle and expels blood into the pulmonary artery.
- Blood pump assemblies are introduced surgically or percutaneously during a cardiac procedure through the vascular system. In one common approach, pump assemblies are inserted by a catheterization procedure through the femoral artery using a peel-away introducer sheath.
- the peel-away introducer sheath is inserted into the femoral artery through an arteriotomy to create an insertion path for the pump assembly. A portion of the pump assembly is then advanced through an inner lumen of the introducer and into the artery. Once the pump assembly has been inserted, the peel-away introducer sheath can be peeled away. A repositioning sheath can then be advanced over the pump assembly and into the arteriotomy. Replacing the introducer sheath with the repositioning sheath can prevent blood clot formation in the introducer sheath, prevent or reduce bleeding from the arteriotomy, and allow blood to flow through the femoral artery to the leg. But after the introducer sheath is removed, wire access to the artery is lost. Loss of the guidewire access makes it more difficult to close the vessel after the procedure or to exchange devices in the arteriotomy.
- peel-away introducer sheath in the arteriotomy for extended durations of time.
- the extended presence of the peel-away sheath in the arteriotomy can reduce recoil of the arteriotomy and thus increase the final diameter of the arteriotomy. This increase in diameter can increase the risk of bleeding through the arteriotomy once the peel-away introducer sheath is finally removed.
- the extended presence of the peel-away sheath in the artery can reduce perfusion through the femoral artery, thereby increasing the risk of ischemia.
- clinicians sometimes choose to monitor a patient's arterial pressure during the catheterization procedure. Measurement of the patient's arterial pressure often requires the placement of an additional catheter. The presence of the additional catheter can add bulk to the operating area and requires entry into the arterial system via another access point.
- the dual lumen sheath can be inserted into an arteriotomy after an introducer sheath is removed to maintain guidewire access to the arteriotomy.
- the dual lumen sheath includes a first lumen sized for passage of a portion of a percutaneous pump and a second lumen sized for the insertion of a guidewire.
- the second lumen receives a guidewire to be inserted into the arteriotomy alongside a percutaneous pump to maintain guidewire access to the insertion path of the percutaneous pump.
- the dual lumen sheath also includes a removable stylet that is inserted into the second lumen to reduce the risk of blood clot formation in the second lumen during the medical procedure. Maintaining the patency of the second lumen is particularly helpful in procedures having a longer duration (e.g., six hours or longer).
- the removable stylet may be reversibly coupled to the dual lumen sheath during insertion of the dual lumen sheath into the arteriotomy and during the medical procedure. Before the percutaneous pump is removed, the stylet is removed from the second lumen to allow insertion of the guidewire through the second lumen.
- the patency of the guidewire port is maintained using a drug or nondrug coating applied to the second lumen.
- the second lumen is flushed with a liquid at a controlled rate to maintain patency.
- the dual lumen sheath also includes a rotatable connection to a stabilizing structure (e.g., suture pads).
- a stabilizing structure e.g., suture pads.
- the rotatable connection allows the outlet of the second lumen at the distal end of the sheath to be rotated away from an arterial wall. This can facilitate the insertion of the guidewire by allowing the guidewire to be inserted in a direction not directly against the arterial wall, thereby reducing the friction associated with insertion of the guidewire. Additionally, the rotation allows the port for the second lumen to lie flat against the patient when the second lumen is not in use.
- the second lumen provides a number of possible other advantages. For example, it also allows arterial pressure to be transduced without the need for an additional catheter. Transducing the pressure can allow a physician to determine when the dual lumen sheath has been inserted to a sufficient depth. If the second lumen is used to transduce pressure, the rotation of the guidewire outlet enabled by the rotatable connection to the stabilizing structure can improve the reliability of the pressure measurement by keeping the outlet of the second lumen off of the arterial wall. Additionally, the second lumen can be used to determine the depth of insertion without a pressure transducer. For example, the depth of insertion can be determined by observing the onset of blood flow through the second lumen (“bleedback”), which is indicative of penetration into the arteriotomy.
- bleedback onset of blood flow through the second lumen
- depth markings can be disposed on an outer surface of the sheath to facilitate measurement of the depth of insertion.
- the depth markings may be radio-opaque. The measurement of the depth of the arteriotomy relative to the patient's skin can facilitate the subsequent use of certain vessel closure tools which may require such a measurement.
- a sheath assembly for the insertion of a percutaneous pump includes a tubular sheath body dimensioned for insertion into a blood vessel through a vessel aperture.
- the tubular sheath body includes a wall having a proximal end portion, a distal end portion, a longitudinal axis, an outer surface, an inner surface defining a first lumen substantially parallel to the longitudinal axis, and a second lumen disposed within the wall between the inner surface and the outer surface and extending from the proximal end portion to the distal end portion.
- the first lumen is dimensioned to allow passage of a portion of the percutaneous pump, and the second lumen is dimensioned for passage of a guidewire.
- a stylet is removably positioned to substantially occlude the second lumen.
- the stylet has a proximal end configured to be releasably secured to the sheath assembly.
- the length of the stylet is substantially equal to the length of the second lumen.
- the stylet is radio-opaque or includes radio-opaque marker bands to show the distance of the sheath in the blood vessel.
- the sheath assembly also includes a hub coupled to the proximal end portion of the sheath body and including a first port in fluid communication with the first lumen, and a second port in fluid communication with the second lumen, wherein the second port is configured to secure the proximal end of the stylet.
- the sheath body may be dimensioned to be introduced through a percutaneous access site of about 20 Fr (6.67 mm) or less (e.g., 19 Fr, 18 Fr, 17 Fr, 16 Fr, 15 Fr, 14 Fr, 13 Fr, 12 Fr, 10 Fr, 9 Fr, 8 Fr, 6 Fr, or less).
- the distal end portion of the sheath body is tapered and includes a tapered surface extending to a distal end face, the distal end face being substantially orthogonal to the longitudinal axis of the sheath body.
- the second lumen has an outlet extending through the tapered surface of the distal end portion of the sheath body.
- the second lumen may be coated with an antithrombogenic agent.
- the outer surface of the wall of the tubular sheath body includes a hydrophilic coating or any other suitable coating to prevent tissue adhesion.
- the outer surface of the wall includes markings for determining a depth of insertion, for example with evenly spaced markings on the outer surface of the wall.
- the sheath assembly of claim also includes a stabilizing structure rotatably coupled to the tubular sheath body.
- the stabilizing structure may be rotatable about the longitudinal axis.
- the stabilizing structure includes a feature configured for suturing to a patient.
- the stabilizing structure may include a pair of suture wings, each wing having a plurality of ribs for securing sutures.
- a method for maintaining guidewire access includes inserting a sheath into a blood vessel through a percutaneous insertion path and along a portion of a percutaneous pump, wherein the sheath has a first lumen and a second lumen, maintaining the sheath in the vessel for more than 6 hours while preventing blood clot formation from occluding the second lumen, and inserting a guidewire through the second lumen into the percutaneous insertion path after the more than 6 hours.
- maintaining the patency includes inserting a stylet into the second lumen for more than 6 hours, and removing the stylet before inserting the guidewire. In certain implementations, maintaining the patency includes flushing the second lumen with purge fluid. In some implementations, the method the method also includes removing the sheath while maintaining the guidewire in the percutaneous insertion path. In certain implementations, the method also includes inserting a percutaneous tool over the guidewire into the percutaneous insertion path after the sheath is removed. In some implementations, the method also includes coupling a sensor to the proximal inlet of the second lumen and transducing arterial pressure at the distal outlet of the second lumen using the sensor.
- the method also includes rotating the sheath relative to a support structure when the pressure measurement indicates that the distal outlet is occluded by an arterial wall. In some implementations, the method also includes determining a depth of insertion from the pressure measurement. The depth of insertion may be determined using depth markers disposed on an outer surface of the sheath.
- FIG. 1 shows a top view of an illustrative dual lumen sheath for arterial access
- FIG. 2 shows a lateral section view of the dual lumen sheath of FIG. 1 ;
- FIG. 3 shows a transverse cross section of the distal portion of the dual lumen sheath of FIG. 1 ;
- FIG. 4 shows a detailed section view of a distal portion of the dual lumen sheath of FIG. 1 ;
- FIG. 5 shows the dual lumen sheath of FIG. 1 inserted into a blood vessel of a patient over a percutaneous pump
- FIG. 6 shows an illustrative process for maintaining guidewire access.
- the systems, methods, and devices described herein provide a dual lumen sheath having a first lumen sized for passage of a portion of a percutaneous pump and a second lumen sized for insertion of a guidewire.
- the second lumen is positioned to allow the guidewire to be inserted into the insertion path of the percutaneous pump. This allows guidewire access to the insertion path to be maintained even after the percutaneous pump and dual lumen sheath are retracted.
- the guidewire access allows one or more other tools (e.g., a vessel closure tool) to be subsequently inserted into the same insertion path to facilitate vessel closure or any other medical procedures involving guidewire access.
- the physician can remove the introducer sheath earlier in a medical procedure. Earlier removal of the introducer sheath allows the insertion path to recoil to a smaller diameter, thereby reducing the risk of bleeding through the access site.
- the systems, methods, and devices described herein also include a stylet that maintains the patency of the second lumen.
- the stylet is used to occlude the second lumen when the second lumen is not being used for insertion of a guidewire or for pressure measurement.
- the removable stylet may be positioned within the second lumen during insertion of the dual lumen sheath into the arteriotomy and during the operation of the percutaneous pump. Before the percutaneous pump is removed, the stylet is removed from the second lumen to allow insertion of the guidewire through the second lumen.
- the occlusion of the second lumen with the stylet can impede blood clot formation in the second lumen during medical procedures having a long duration (e.g., six hours or greater).
- blood clot formation is prevented using a drug or nondrug coating applied to the second lumen.
- blood clot formation is impeded by flushing the second lumen with a liquid at a controlled rate.
- the dual lumen sheath may also include a rotatable connection to a stabilizing structure (e.g., suture wings).
- a stabilizing structure e.g., suture wings.
- the rotatable connection allows the outlet of the second lumen at the distal end of the sheath to be rotated away from an arterial wall. This can facilitate the insertion of the guidewire by allowing the guidewire to be inserted in a direction not directly against the arterial wall, thereby reducing the friction associated with insertion of the guidewire. Additionally, the rotation allows the port for the second lumen to lie substantially flat against the patient when the second lumen is not in use.
- the second lumen can also establish fluid communication between a guidewire port and the interior of the blood vessel.
- This can allow arterial pressure measurement (e.g., by a pressure transducer) during a procedure without the use of a separate catheter. Measuring the arterial pressure can allow a physician to detect when the dual lumen sheath has been inserted to a sufficient depth into the vessel.
- the rotation of the guidewire outlet enabled by the rotatable connection to the stabilizing structure can improve the reliability of the pressure measurement by keeping the outlet of the second lumen off of the arterial wall.
- FIG. 1 shows an illustrative dual lumen sheath assembly 100 for maintaining arterial access, according to certain implementations.
- FIG. 2 shows a lateral section view of the sheath assembly 100 taken along section line 2 - 2
- FIG. 3 shows a transverse cross-section of a distal portion of the sheath assembly 100 taken along section line 3 - 3 .
- the sheath assembly 100 includes a tubular sheath body 102 , a stylet 120 , a hub 126 , and a stabilizing structure 150 .
- the tubular sheath body 102 is dimensioned for insertion into a blood vessel through a vessel aperture.
- the tubular sheath body 102 is dimensioned for insertion into a femoral artery through an arteriotomy.
- the majority of the tubular sheath body 102 may have a substantially uniform outer diameter 101 of about 10 Fr, 11 Fr, 12 Fr, 13, Fr, 14 Fr, 15 Fr, 16 Fr, 17 Fr, 20 Fr, or any other suitable diameter.
- the tubular sheath body may be dimensioned to be introduced through a percutaneous access site of about 20 Fr (6.67 mm) or smaller (e.g., 19 Fr, 18 Fr, 17 Fr, 16 Fr, 15 Fr, 14 Fr, 13 Fr, 12 Fr, 10 Fr, 9 Fr, 8 Fr, 6 Fr, or less).
- the tubular sheath body may have a length of about 80 mm, 100 mm, 120 mm, 140 mm, 160 mm, or any other suitable length. Additionally, the tubular sheath body 102 may be made of a flexible material, such as polyether block amides or any other suitable polymer, to reduce the stress on the blood vessel aperture.
- the tubular sheath body 102 includes a wall 104 , a proximal end portion 106 , a distal end portion 108 , a longitudinal axis 110 , an outer surface 112 , a first inner surface 114 , a second inner surface 115 , a first lumen 116 , and a second lumen 118 .
- the distal end portion 108 of the tubular sheath body 102 includes a tapered surface 103 , a first outlet 105 in fluid communication with the first lumen 116 , and a second outlet 107 in fluid communication with the second lumen 118 .
- the tapered surface 103 has an outer diameter graduated from 11 Fr to 15 Fr (3.667 mm to 5 mm). The graduation in the tapered surface 103 may permit the sheath to be inserted to a variable depth as necessary to plug the gap between the percutaneous pump and the insertion site.
- the outer surface 112 of the tubular sheath body 102 may be coated with a hydrophilic coating to ease insertion of the tubular sheath body 102 into the arteriotomy.
- a hydrophilic coating can also prevent adhesions to the blood vessel wall. Such adhesions could damage the vessel if the sheath is removed after having been in the blood vessel for an extended period of time (e.g., many days). The risk of adhesion to the blood vessel wall can increase as the duration of a procedure increases.
- the outer surface 112 of the tubular sheath body 102 includes depth markings.
- the depth markings may be pad printed or laser etched onto the outer surface 112 .
- the depth markings are radio-opaque.
- the depth markings may be in centimeters, inches, millimeters, or any other suitable unit of measurement or combination thereof.
- the first inner surface 114 of the tubular sheath body defines the first lumen 116 .
- the first lumen 116 is dimensioned to allow passage of a portion of the percutaneous pump.
- the first lumen 116 extends from the proximal end portion 106 of the tubular sheath body 102 to the distal end portion 108 , substantially parallel to the longitudinal axis 110 .
- the second lumen 118 is disposed within the wall 104 between the inner surface 114 and the outer surface 112 .
- the second lumen 118 extends from the proximal end portion 106 of the tubular sheath body 102 to the distal end portion 108 , offset from and substantially parallel to the longitudinal axis 110 .
- the second lumen 118 is dimensioned for the passage of a guidewire and is defined by the second inner surface 115 (as shown in FIG. 3 ).
- the second inner surface 115 may include a drug or non-drug coating to prevent blood clot formation in the second lumen 118 .
- the second inner surface is coated with heparin.
- the second lumen 118 terminates at the second outlet 102 formed in the tapered surface 103 .
- the second outlet 102 is adjacent to the first outlet 105 of the first lumen 116 .
- the second lumen 118 may be used to maintain or regain guidewire access to the insertion path of a percutaneous pump inserted through the first lumen 116 .
- This allows guidewire access to the insertion path to be maintained even after an introducer sheath is removed.
- the guidewire access allows one or more other tools to be subsequently inserted into the same insertion path to facilitate vessel closure or any other medical procedures involving guidewire access.
- the guidewire access may permit the subsequent insertion of a vessel closure tool or a micro pressure measurement catheter (e.g., MILLAR Mikro-Tip® pressure catheter).
- a micro pressure measurement catheter may allow measurement of pressure in the left ventricle or any other suitable pressure.
- the second lumen enables a physician to maintain guidewire access after the introducer sheath is removed, the physician can remove the introducer sheath earlier. Earlier removal of the introducer sheath allows the vessel aperture to recoil to a smaller diameter, thereby reducing the risk of bleeding through the access site.
- rotating the tubular sheath body 102 allows the position of the second outlet 107 to be adjusted. This can allow a user to keep the second outlet 107 off of a blood vessel wall to ease insertion of a guidewire or to increase the accuracy of an arterial pressure measurement.
- the tubular sheath body 102 is connected at its proximal end portion 106 to the hub 126 .
- the hub 126 includes a first port 128 , a second port 130 , second port threads 131 , and a bearing 136 .
- the second port 130 is connected to the second lumen 118 so that a guidewire can be inserted through the second port 130 into the second lumen 118 and out of the second outlet 107 .
- the stylet 120 can be inserted into the second port 130 to seal the second lumen 118 (as shown in FIGS. 1, 2, and 3 ).
- the stylet 120 includes a head 121 , a stylet body 122 , a rounded end 123 , and threads 126 .
- the stylet body 122 is sized to substantially occlude the second lumen 118 when the stylet 120 is inserted into the second lumen 118 .
- the stylet body 122 is made of a formable or ductile material, such as a metal. This may allow the stylet to be formed, either during the medical procedure or before, into a shape that reduces stress on the vessel aperture.
- the stylet 120 is radio-opaque or includes radio-opaque marker bands to show the depth of the tubular sheath body 102 in a blood vessel.
- the threads 124 of the stylet head 121 reversibly couple with the second port threads 131 to hold the stylet 120 within the second lumen 118 .
- the stylet head 121 forms a liquid tight seal across the second port 130 , which prevents the leakage of blood out of the blood vessel.
- a pressure bag is connected to the second port 130 using the threads 131 .
- the pressure bag can be used to flush the second lumen 118 with a fluid to maintain the patency of the second lumen 118 .
- An infusion pump may be used in combination with the pressure bag to regulate the flow rate of liquid into the patient.
- the flow rate may be limited to 1 mL/hr, 2 mL/hr, 5 mL/hr, 10 mL/hr, or any other suitable flow rate.
- a pressure measuring device is connected to the second port 130 to measure pressure within the vessel 10 . This pressure measurement can be used to determine when the second port 102 has been inserted sufficiently deep into the blood vessel aperture. For example, when a pressure about equal to arterial pressure is measured at the second port 130 , the second outlet 107 may be in fluid communication with the blood vessel. The pressure measurement can also be used to monitor arterial pressure in the patient's blood vessel during a medical procedure. This may allow an arterial pressure measurement to be taken without the use of an additional catheter, which may reduce the amount of equipment necessary in the potentially crowded operating area.
- the first port 128 of the hub 126 allows the passage of the percutaneous pump (not shown).
- the first port 128 includes a cap 132 and a seal 134 .
- the cap 132 snaps into the first port 128 to hold the seal 134 against the first port 128 .
- the cap 132 and seal 134 together act as a hemostatic valve and form a liquid tight seal between the percutaneous pump and the first port 128 .
- the seal 134 is formed of an elastomer, such as silicone, so that it can flex to seal around a portion of the percutaneous pump.
- the hub 126 is coupled to the stabilizing structure 150 by the bearing 136 .
- the stabilizing structure 150 includes wings 152 and 154 , suture holes 156 - 159 , ribs 160 - 162 , and a bearing surface 164 that mates with the bearing 136 .
- the mating of the bearing surface 164 of the stabilizing structure 150 with the bearing 136 of the hub 126 allows rotation of the hub 126 relative to the stabilizing structure 150 . As discussed above, this rotation allows the tubular sheath body 102 to be rotated such that the second outlet 107 is oriented away from a vessel wall. Additionally, this rotation allows the second port 130 to lie flat against a patient when the second port 130 is not in use.
- the suture holes 156 - 159 allow the wings 152 and 154 to be sutured to a patient to stabilize the sheath assembly 100 . While only four suture holes 156 - 159 are shown, any suitable number of suture holes may be used.
- the stabilizing structure 150 is also designed to be easily attached to a vascular graft with umbilical tape or sutures. This feature is beneficial during axillary insertions or any other insertions which require pump placement through a vascular graft. Additionally, in some implementations, the stabilizing structure 150 is coupled to a patient using ribs 160 - 162 . For example, sutures may be wrapped around the outer surface 165 of the stabilizing structure between the ribs 160 - 162 .
- the ribs 160 - 162 prevent the sutures from sliding off of the outer surface 165 along the longitudinal axis 110 .
- other stabilizations devices such as surgical tape, a STATLOCK®. stabilization device (Bard Access Systems, Inc., Salt Lake City, Utah), or any other suitable adhesive stabilization device, may be coupled to the stabilizing structure 150 around the ribs 160 - 162 .
- FIG. 4 shows a detailed section view of the distal portion 108 of the dual lumen sheath assembly 100 of FIGS. 1, 2, and 3 .
- the distal portion 108 includes the tapered surface 103 , the first outlet 105 , the second outlet 107 , and distal portions of the stylet body 122 , the first lumen 116 , and the second lumen 118 .
- the first lumen 116 includes a proximal section 116 a having an inner diameter 117 , a distal section 116 b having an inner diameter 217 which is less than the inner diameter 117 , and a restriction 216 therebetween.
- the inner diameter 117 is about 13 Fr (4.333 mm), and the inner diameter 217 is about 9 Fr (3 mm).
- the restriction 216 allows the distal section 116 b of the first lumen 116 to form a tighter fit with the percutaneous pump to prevent or reduce blood leakage without causing unacceptably high friction in the proximal section 116 a .
- the second lumen 118 includes a proximal section 118 a having a diameter 119 , a distal section 118 b having a diameter 219 that is less than the diameter 119 , and a restriction 218 therebetween.
- the diameter 119 is about 1.1 mm and the diameter 219 is about 1 mm.
- the restriction 218 allows a tighter fit between the stylet body 122 and the second lumen 118 at the distal section 118 a to reduce blood ingress, while allowing a clearance in the proximal section 118 b to reduce friction.
- the friction between the second lumen 118 and the stylet body 122 is further reduced by the rounding of the end 123 of the stylet body 122 .
- the rounded end 123 is located adjacent to the second outlet 107 when the stylet 120 is fully inserted into the second lumen 118 , thereby preventing or reducing blood ingress into the second lumen 118 .
- FIG. 5 shows the dual lumen sheath assembly 100 of FIG. 1 inserted into a blood vessel 10 of a patient over a percutaneous pump 60 .
- the percutaneous pump 60 includes a pump head 66 and a catheter body 62 .
- the percutaneous pump 60 may be an intravascular blood pump, a blood pump driven by flexible drive shaft, a blood pump including an implantable motor, a blood pump having an expandable pump rotor, or any other suitable pump.
- the dual lumen sheath assembly 100 is advanced into the blood vessel 10 over the catheter body 62 of the percutaneous pump 60 through the blood vessel aperture 12 in the direction indicated by arrow 70 .
- the first lumen 116 of the dual lumen sheath assembly 100 may be threaded on the catheter body 62 when the percutaneous pump 60 is initially inserted into the blood vessel 10 .
- the blood vessel 10 may be a femoral artery, and the blood vessel aperture 12 may be an arteriotomy.
- the blood vessel aperture 12 may have an opening slightly larger than the diameter 64 of the catheter body 62 .
- the tubular body 102 of the dual lumen sheath assembly 100 may effectively plug the gap between the blood vessel aperture 12 and the catheter by 64 when the sheath assembly 100 is advanced into the blood vessel 10 over the catheter body 62 .
- the outer diameter 101 of the tubular sheath body 102 may be graduated as discussed above to so that the diameter 101 of the tubular sheath body 102 increases from its distal end portion 108 to its proximal end portion 106 . This can allow the tubular sheath body 102 to be inserted farther into the blood vessel 100 to plug a larger gap between the blood vessel aperture 12 and the catheter body 62 . The plugging effect of the tubular sheath body 102 can reduce or prevent bleeding out of the blood vessel aperture 12 .
- the tubular sheath body 102 is flexible so that the tubular sheath body 102 can form a bend 80 which allows the tubular sheath body 102 to follow the contours of the vessel 10 . This flexibility can reduce the stress placed on the blood vessel aperture 12 by reducing the force required to deform the tubular sheath body 102 .
- the dual lumen sheath assembly 100 may be fixed relative to the catheter body 62 .
- This fixation may be achieved by fixing the stabilizing structure 150 to the patient's tissue 14 . In some implementations, this is achieved by suturing wings (not shown) of the stabilizing structure 150 to the patient tissue 14 .
- the stabilizing structure 150 is attached to a vascular graft with umbilical tape or sutures. This may be performed during axillary insertions or any other insertions which require pump placement through a vascular graft.
- fixing the placement of the dual lumen sheath assembly 100 may be achieved by tightening the seal 134 around the catheter body 62 or by means of a separate anchoring ring.
- the second port 130 may be rotated relative to the stabilizing structure 150 so that the second port 130 lies flat against the patient tissue 14 .
- a physician may begin operation of the percutaneous pump 60 .
- the percutaneous pump 60 may be operated during a percutaneous coronary intervention (PCI), open-heart surgery, heart valve replacement surgery, or during treatment of acute myocardial infarction (AMI), cardiogenic shock, or ST segment elevation myocardial infarction (STEMI), as well as any other suitable medical procedure.
- PCI percutaneous coronary intervention
- AMI acute myocardial infarction
- STEMI ST segment elevation myocardial infarction
- the percutaneous pump 60 is operated for an extended period of time, such as greater than six hours, greater than 12 hours, greater than 24 hours, greater than 48 hours, greater than 72 hours, greater than one week, or any other suitable duration of time.
- a stylet (not shown in FIG. 5 ), such as the stylet 120 from FIGS. 1-4 , may be positioned within the second lumen 118 during insertion of the dual lumen sheath assembly 100 to prevent blood ingress into the second lumen 118 , which could lead to clotting that could obstruct the second lumen 118 or to bleeding out of the second port 130 .
- a pressure bag is connected to the second port 130 in place of the stylet to maintain the patency of the second lumen 118 .
- An infusion pump may be used in combination with the pressure bag to regulate the flow rate of liquid into the patient.
- the flow rate may be limited to 1 mL/hr, 2 mL/hr, 5 mL/hr, 10 mL/hr, or any other suitable flow rate.
- a pressure measuring device is connected to the second port 130 to measure the pressure within the vessel 10 . This pressure measurement can be used to determine when the second port 102 has been inserted sufficiently deep into the blood vessel aperture 12 .
- the second outlet 107 may be in fluid communication with the blood vessel 10 .
- the depth of the blood vessel aperture 12 relative to the patient's skin can be measured using depth markings disposed on an outer surface of the sheath. The measurement of this depth can facilitate the subsequent use of certain vessel closure tools which may require such a measurement.
- the pressure measurement can also be used to monitor arterial pressure in the blood vessel 10 during a medical procedure. This may allow an arterial pressure measurement to be taken without the use of an additional catheter, which may reduce the amount of equipment necessary in the potentially crowded operating area.
- the second lumen 118 can allow a determination of the depth of insertion without a pressure transducer by allowing observation of the onset of blood flow through the second lumen 118 (“bleedback”), which is indicative of penetration into the blood vessel aperture 12 .
- a guidewire 50 is inserted through the second port 130 into the second lumen 118 and out the second outlet 107 into the blood vessel 10 .
- the guidewire 50 enters the same insertion path as the percutaneous pump 60 , thereby maintaining access to the insertion path. If a stylet was used during insertion of the dual lumen sheath assembly 100 , the stylet is removed before insertion of the guidewire 50 .
- the guidewire 50 has an outer diameter that approximately matches the inner diameter of the second outlet 107 to prevent blood from flowing out of the blood vessel 10 through the second port 130 .
- the guidewire may have an outer diameter of about 1 mm.
- a seal at the second port 130 is included to further ensure that no blood exits the second port 130 while the guidewire 50 is in place.
- the percutaneous pump 60 and the dual lumen sheath assembly 100 may be removed through the blood vessel aperture 12 while the guidewire 50 is left in place.
- the tubular sheath body 102 may be coated with a hydrophilic coating or any other suitable coating that prevents adhesions to the blood vessel 10 , thereby facilitating removal of the tubular sheath body 102 without damaging the blood vessel 10 .
- the removal of the dual lumen sheath assembly 100 and percutaneous pump 60 while the guidewire 50 is left in place allows guidewire access to the insertion path 11 to be maintained.
- the removal of the percutaneous pump 60 requires the concurrent removal of the dual lumen sheath assembly 100 because the diameter 68 of the pump head 66 cannot pass through the first lumen 116 .
- the inner diameter of the first lumen 116 is sized to fit tightly around the diameter 64 of the catheter body 62 , but cannot accommodate the larger diameter 68 of the pump head 66 .
- the first lumen 116 is not available to be used to maintain guidewire access to the insertion path 11 .
- the second lumen 118 is necessary to maintain guidewire access to the insertion path 11 .
- the guidewire 50 remains in the blood vessel 10 and the insertion path 11 .
- another tool may be inserted over the guidewire 50 into the insertion path 11 .
- a vascular closure device is inserted into the insertion path 11 using the guidewire 50 .
- the vascular closure device may be the VASOSEAL vascular sealing device, the ANGIO-SEAL bio-absorbable active closure system, the PERCLOSE vascular sealing device, or any other suitable vascular closure device or combination of vascular closure devices.
- FIG. 6 shows an illustrative process 600 for maintaining guidewire access.
- the illustrative process 600 may be performed using the dual lumen sheath assembly 100 or any other suitable sheath tool.
- a sheath is inserted into a blood vessel through a percutaneous insertion path and along a portion of a percutaneous pump.
- the sheath has a first lumen and a second lumen.
- the blood vessel may be an artery, such as the femoral artery.
- the insertion path passes through a blood vessel aperture (e.g., an arteriotomy).
- the percutaneous pump is inserted into the insertion path using an introducer prior to step 602 . Therefore, the percutaneous pump guides the sheath into the existing insertion path.
- the percutaneous pump may be an intravascular blood pump, a blood pump driven by flexible drive shaft, a blood pump including an implantable motor, a blood pump having an expandable pump rotor, or any other suitable pump.
- the first lumen of the sheath may be sealed against the percutaneous pump by a hemostatic valve to prevent leakage of blood from the blood vessel out of the patient.
- the sheath is only inserted into the vessel as deep as is necessary to close the gap between the percutaneous pump and the vessel aperture to prevent bleeding.
- the pressure within the vessel can be detected using the second lumen. For example, a detected pressure about equal to arterial pressure may indicate that the outlet of the second lumen has been inserted into the blood vessel.
- the second lumen can allow a determination of the depth of insertion without a pressure transducer by allowing observation of the onset of blood flow through the second lumen (“bleedback”), which is indicative of penetration into the blood vessel aperture.
- the depth of the blood vessel aperture relative to the patient's skin can be measured using depth markings disposed on an outer surface of the sheath.
- the depth markings are radio-opaque and can be imaged using a tomographic imaging modality (e.g., CT, MRI, X-ray). The measurement of this depth can facilitate the subsequent use of certain vessel closure tools which may require such a measurement.
- the second lumen can be used to measure arterial pressure during the procedure.
- the sheath is maintained in the vessel for about six hours or more while blood clot formation is prevented from occluding the second lumen.
- the sheath may be maintained in the vessel for 6 hours, 12 hours, 24 hours, 48 hours, 72 hours, one week, two weeks, or any other suitable duration of time.
- Blood clot formation in the second lumen may be prevented during this time using a stylet that temporarily occludes the second lumen.
- the stylet 120 of FIGS. 1-3 may be used to temporarily occlude the second lumen.
- blood clot formation in the second lumen is prevented or reduced using a drug or nondrug coating in the second lumen.
- the coating may include heparin or any other suitable substance.
- blood clot formation in the second lumen is prevented or reduced by flushing the second lumen with a liquid (e.g., saline solution, glucose solution, or any other suitable solution).
- a liquid e.g., saline solution, glucose solution, or any other suitable solution.
- a guidewire is inserted through the second lumen into the percutaneous insertion path after the about six hours or more. If a stylet was used to temporarily occlude the second lumen, the stylet is removed before inserting the guidewire.
- the percutaneous pump inserted through the first lumen may be removed after insertion of the guidewire.
- the sheath may be removed from the percutaneous insertion path while the guidewire remains in place. This can allow another tool (e.g., an access closure tool) to be inserted into the insertion path.
- an access closure tool e.g., an access closure tool
- the physician is able to remove the introducer earlier in a procedure. This can allow greater recoil of the blood vessel aperture, thereby reducing the risk of bleeding. For example, removing the introducer within an hour of insertion may allow a recoil of about 2 to 3 Fr (0.667 mm to 1 mm).
- the sheath assembly may be used to provide guidewire access for procedures of a short duration (e.g., less than six hours).
- the stylet may be omitted in some implementations in which the patency of the second lumen is adequately maintained by other means.
- the second lumen is flushed with a liquid, either intermittently or continuously.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Mechanical Engineering (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Transplantation (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- External Artificial Organs (AREA)
- Farming Of Fish And Shellfish (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
A sheath assembly for the insertion of a percutaneous pump includes a tubular sheath body dimensioned for insertion into a blood vessel through a vessel aperture. The tubular sheath body includes a wall having a proximal end portion, a distal end portion, a longitudinal axis, an outer surface, an inner surface defining a first lumen substantially parallel to the longitudinal axis, and a second lumen disposed within the wall between the inner surface and the outer surface and extending from the proximal end portion to the distal end portion. The first lumen is dimensioned to allow passage of a portion of the percutaneous pump, and the second lumen is dimensioned for passage of a guidewire. A stylet is removably positioned to substantially occlude the second lumen. The stylet has a proximal end releasably secured to the sheath assembly.
Description
- The present application is a divisional of U.S. patent application Ser. No. 14/827,741, filed Aug. 17, 2015, the disclosure of which is hereby incorporated by reference in its entirety.
- A blood pump, such as a percutaneous intracardiac blood pump assembly, is introduced in the heart to deliver blood from the heart into an artery. When deployed in the heart, a blood pump assembly pulls blood from the left ventricle of the heart and expels blood into the aorta, or pulls blood from the right ventricle and expels blood into the pulmonary artery. Blood pump assemblies are introduced surgically or percutaneously during a cardiac procedure through the vascular system. In one common approach, pump assemblies are inserted by a catheterization procedure through the femoral artery using a peel-away introducer sheath.
- The peel-away introducer sheath is inserted into the femoral artery through an arteriotomy to create an insertion path for the pump assembly. A portion of the pump assembly is then advanced through an inner lumen of the introducer and into the artery. Once the pump assembly has been inserted, the peel-away introducer sheath can be peeled away. A repositioning sheath can then be advanced over the pump assembly and into the arteriotomy. Replacing the introducer sheath with the repositioning sheath can prevent blood clot formation in the introducer sheath, prevent or reduce bleeding from the arteriotomy, and allow blood to flow through the femoral artery to the leg. But after the introducer sheath is removed, wire access to the artery is lost. Loss of the guidewire access makes it more difficult to close the vessel after the procedure or to exchange devices in the arteriotomy.
- To maintain guidewire access, some physicians leave the peel-away introducer sheath in the arteriotomy for extended durations of time. The extended presence of the peel-away sheath in the arteriotomy can reduce recoil of the arteriotomy and thus increase the final diameter of the arteriotomy. This increase in diameter can increase the risk of bleeding through the arteriotomy once the peel-away introducer sheath is finally removed. Furthermore, the extended presence of the peel-away sheath in the artery can reduce perfusion through the femoral artery, thereby increasing the risk of ischemia.
- Additionally, clinicians sometimes choose to monitor a patient's arterial pressure during the catheterization procedure. Measurement of the patient's arterial pressure often requires the placement of an additional catheter. The presence of the additional catheter can add bulk to the operating area and requires entry into the arterial system via another access point.
- Systems, methods, and devices for an improved dual lumen repositioning sheath are presented. The dual lumen sheath can be inserted into an arteriotomy after an introducer sheath is removed to maintain guidewire access to the arteriotomy. The dual lumen sheath includes a first lumen sized for passage of a portion of a percutaneous pump and a second lumen sized for the insertion of a guidewire. The second lumen receives a guidewire to be inserted into the arteriotomy alongside a percutaneous pump to maintain guidewire access to the insertion path of the percutaneous pump. By maintaining guidewire access using the second lumen of the dual lumen sheath, the introducer sheath can be removed from a patient without losing the guidewire access. This allows the physician to remove the introducer sheath earlier in a procedure (e.g., 1 hour, 30 minutes, 10 minutes, 5 minutes, or immediately after successful insertion of the percutaneous pump), which allows the blood vessel aperture to recoil to a smaller diameter compared to the diameter it would assume if the introducer sheath were left in the patient for longer. For example, a recoil of 2 to 3 French (0.667 mm to 1 mm) may be achieved if the introducer sheath is removed before the blood vessel aperture permanently relaxes to the larger diameter of the introducer sheath.
- The dual lumen sheath also includes a removable stylet that is inserted into the second lumen to reduce the risk of blood clot formation in the second lumen during the medical procedure. Maintaining the patency of the second lumen is particularly helpful in procedures having a longer duration (e.g., six hours or longer). The removable stylet may be reversibly coupled to the dual lumen sheath during insertion of the dual lumen sheath into the arteriotomy and during the medical procedure. Before the percutaneous pump is removed, the stylet is removed from the second lumen to allow insertion of the guidewire through the second lumen. In some implementations, the patency of the guidewire port is maintained using a drug or nondrug coating applied to the second lumen. In certain implementations, the second lumen is flushed with a liquid at a controlled rate to maintain patency.
- In some embodiments, the dual lumen sheath also includes a rotatable connection to a stabilizing structure (e.g., suture pads). The rotatable connection allows the outlet of the second lumen at the distal end of the sheath to be rotated away from an arterial wall. This can facilitate the insertion of the guidewire by allowing the guidewire to be inserted in a direction not directly against the arterial wall, thereby reducing the friction associated with insertion of the guidewire. Additionally, the rotation allows the port for the second lumen to lie flat against the patient when the second lumen is not in use.
- The second lumen provides a number of possible other advantages. For example, it also allows arterial pressure to be transduced without the need for an additional catheter. Transducing the pressure can allow a physician to determine when the dual lumen sheath has been inserted to a sufficient depth. If the second lumen is used to transduce pressure, the rotation of the guidewire outlet enabled by the rotatable connection to the stabilizing structure can improve the reliability of the pressure measurement by keeping the outlet of the second lumen off of the arterial wall. Additionally, the second lumen can be used to determine the depth of insertion without a pressure transducer. For example, the depth of insertion can be determined by observing the onset of blood flow through the second lumen (“bleedback”), which is indicative of penetration into the arteriotomy. Regardless of whether a pressure transducer or a bleedback indicator is used, depth markings can be disposed on an outer surface of the sheath to facilitate measurement of the depth of insertion. The depth markings may be radio-opaque. The measurement of the depth of the arteriotomy relative to the patient's skin can facilitate the subsequent use of certain vessel closure tools which may require such a measurement.
- In one aspect, a sheath assembly for the insertion of a percutaneous pump includes a tubular sheath body dimensioned for insertion into a blood vessel through a vessel aperture. The tubular sheath body includes a wall having a proximal end portion, a distal end portion, a longitudinal axis, an outer surface, an inner surface defining a first lumen substantially parallel to the longitudinal axis, and a second lumen disposed within the wall between the inner surface and the outer surface and extending from the proximal end portion to the distal end portion. The first lumen is dimensioned to allow passage of a portion of the percutaneous pump, and the second lumen is dimensioned for passage of a guidewire. A stylet is removably positioned to substantially occlude the second lumen.
- In certain implementations, the stylet has a proximal end configured to be releasably secured to the sheath assembly. In some implementations, the length of the stylet is substantially equal to the length of the second lumen. In certain implementations, the stylet is radio-opaque or includes radio-opaque marker bands to show the distance of the sheath in the blood vessel. In certain implementations, the sheath assembly also includes a hub coupled to the proximal end portion of the sheath body and including a first port in fluid communication with the first lumen, and a second port in fluid communication with the second lumen, wherein the second port is configured to secure the proximal end of the stylet. The sheath body may be dimensioned to be introduced through a percutaneous access site of about 20 Fr (6.67 mm) or less (e.g., 19 Fr, 18 Fr, 17 Fr, 16 Fr, 15 Fr, 14 Fr, 13 Fr, 12 Fr, 10 Fr, 9 Fr, 8 Fr, 6 Fr, or less).
- In some implementations, the distal end portion of the sheath body is tapered and includes a tapered surface extending to a distal end face, the distal end face being substantially orthogonal to the longitudinal axis of the sheath body. In certain implementations, the second lumen has an outlet extending through the tapered surface of the distal end portion of the sheath body. The second lumen may be coated with an antithrombogenic agent. In some implementations, the outer surface of the wall of the tubular sheath body includes a hydrophilic coating or any other suitable coating to prevent tissue adhesion. In certain implementations, the outer surface of the wall includes markings for determining a depth of insertion, for example with evenly spaced markings on the outer surface of the wall.
- In certain implementations, the sheath assembly of claim also includes a stabilizing structure rotatably coupled to the tubular sheath body. The stabilizing structure may be rotatable about the longitudinal axis. In some implementations, the stabilizing structure includes a feature configured for suturing to a patient. The stabilizing structure may include a pair of suture wings, each wing having a plurality of ribs for securing sutures.
- In another aspect, a method for maintaining guidewire access includes inserting a sheath into a blood vessel through a percutaneous insertion path and along a portion of a percutaneous pump, wherein the sheath has a first lumen and a second lumen, maintaining the sheath in the vessel for more than 6 hours while preventing blood clot formation from occluding the second lumen, and inserting a guidewire through the second lumen into the percutaneous insertion path after the more than 6 hours.
- In some implementations, maintaining the patency includes inserting a stylet into the second lumen for more than 6 hours, and removing the stylet before inserting the guidewire. In certain implementations, maintaining the patency includes flushing the second lumen with purge fluid. In some implementations, the method the method also includes removing the sheath while maintaining the guidewire in the percutaneous insertion path. In certain implementations, the method also includes inserting a percutaneous tool over the guidewire into the percutaneous insertion path after the sheath is removed. In some implementations, the method also includes coupling a sensor to the proximal inlet of the second lumen and transducing arterial pressure at the distal outlet of the second lumen using the sensor. In certain implementations, the method also includes rotating the sheath relative to a support structure when the pressure measurement indicates that the distal outlet is occluded by an arterial wall. In some implementations, the method also includes determining a depth of insertion from the pressure measurement. The depth of insertion may be determined using depth markers disposed on an outer surface of the sheath.
- Variations and modifications will occur to those of skill in the art after reviewing this disclosure. The disclosed features may be implemented, in any combination and subcombination (including multiple dependent combinations and subcombinations), with one or more other features described herein. The various features described or illustrated above, including any components thereof, may be combined or integrated in other systems. Moreover, certain features may be omitted or not implemented.
- The foregoing and other objects and advantages will be apparent upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which like reference characters refer to like parts throughout, and in which:
-
FIG. 1 shows a top view of an illustrative dual lumen sheath for arterial access; -
FIG. 2 shows a lateral section view of the dual lumen sheath ofFIG. 1 ; -
FIG. 3 shows a transverse cross section of the distal portion of the dual lumen sheath ofFIG. 1 ; -
FIG. 4 shows a detailed section view of a distal portion of the dual lumen sheath ofFIG. 1 ; -
FIG. 5 shows the dual lumen sheath ofFIG. 1 inserted into a blood vessel of a patient over a percutaneous pump; and -
FIG. 6 shows an illustrative process for maintaining guidewire access. - To provide an overall understanding of the systems, method, and devices described herein, certain illustrative embodiments will be described. Although the embodiments and features described herein are specifically described for use in connection with a percutaneous blood pump system, it will be understood that all the components and other features outlined below may be combined with one another in any suitable manner and may be adapted and applied to other types of cardiac therapy and cardiac assist devices, including balloon pumps, cardiac assist devices implanted using a surgical incision, and the like.
- The systems, methods, and devices described herein provide a dual lumen sheath having a first lumen sized for passage of a portion of a percutaneous pump and a second lumen sized for insertion of a guidewire. The second lumen is positioned to allow the guidewire to be inserted into the insertion path of the percutaneous pump. This allows guidewire access to the insertion path to be maintained even after the percutaneous pump and dual lumen sheath are retracted. The guidewire access allows one or more other tools (e.g., a vessel closure tool) to be subsequently inserted into the same insertion path to facilitate vessel closure or any other medical procedures involving guidewire access. Because the second lumen enables a physician to maintain the guidewire access after the introducer sheath is removed, the physician can remove the introducer sheath earlier in a medical procedure. Earlier removal of the introducer sheath allows the insertion path to recoil to a smaller diameter, thereby reducing the risk of bleeding through the access site.
- The systems, methods, and devices described herein also include a stylet that maintains the patency of the second lumen. The stylet is used to occlude the second lumen when the second lumen is not being used for insertion of a guidewire or for pressure measurement. For example, the removable stylet may be positioned within the second lumen during insertion of the dual lumen sheath into the arteriotomy and during the operation of the percutaneous pump. Before the percutaneous pump is removed, the stylet is removed from the second lumen to allow insertion of the guidewire through the second lumen. The occlusion of the second lumen with the stylet can impede blood clot formation in the second lumen during medical procedures having a long duration (e.g., six hours or greater). This allows the second lumen to remain accessible during and after the medical procedure, for example to provide a path for insertion of the guidewire before removing the percutaneous pump. In some implementations, blood clot formation is prevented using a drug or nondrug coating applied to the second lumen. In certain implementations, blood clot formation is impeded by flushing the second lumen with a liquid at a controlled rate.
- The dual lumen sheath may also include a rotatable connection to a stabilizing structure (e.g., suture wings). The rotatable connection allows the outlet of the second lumen at the distal end of the sheath to be rotated away from an arterial wall. This can facilitate the insertion of the guidewire by allowing the guidewire to be inserted in a direction not directly against the arterial wall, thereby reducing the friction associated with insertion of the guidewire. Additionally, the rotation allows the port for the second lumen to lie substantially flat against the patient when the second lumen is not in use.
- The second lumen can also establish fluid communication between a guidewire port and the interior of the blood vessel. This can allow arterial pressure measurement (e.g., by a pressure transducer) during a procedure without the use of a separate catheter. Measuring the arterial pressure can allow a physician to detect when the dual lumen sheath has been inserted to a sufficient depth into the vessel. The rotation of the guidewire outlet enabled by the rotatable connection to the stabilizing structure can improve the reliability of the pressure measurement by keeping the outlet of the second lumen off of the arterial wall.
-
FIG. 1 shows an illustrative duallumen sheath assembly 100 for maintaining arterial access, according to certain implementations.FIG. 2 shows a lateral section view of thesheath assembly 100 taken along section line 2-2, andFIG. 3 shows a transverse cross-section of a distal portion of thesheath assembly 100 taken along section line 3-3. Thesheath assembly 100 includes atubular sheath body 102, astylet 120, ahub 126, and a stabilizingstructure 150. Thetubular sheath body 102 is dimensioned for insertion into a blood vessel through a vessel aperture. In some implementations, thetubular sheath body 102 is dimensioned for insertion into a femoral artery through an arteriotomy. The majority of thetubular sheath body 102 may have a substantially uniformouter diameter 101 of about 10 Fr, 11 Fr, 12 Fr, 13, Fr, 14 Fr, 15 Fr, 16 Fr, 17 Fr, 20 Fr, or any other suitable diameter. The tubular sheath body may be dimensioned to be introduced through a percutaneous access site of about 20 Fr (6.67 mm) or smaller (e.g., 19 Fr, 18 Fr, 17 Fr, 16 Fr, 15 Fr, 14 Fr, 13 Fr, 12 Fr, 10 Fr, 9 Fr, 8 Fr, 6 Fr, or less). The tubular sheath body may have a length of about 80 mm, 100 mm, 120 mm, 140 mm, 160 mm, or any other suitable length. Additionally, thetubular sheath body 102 may be made of a flexible material, such as polyether block amides or any other suitable polymer, to reduce the stress on the blood vessel aperture. - The
tubular sheath body 102 includes awall 104, aproximal end portion 106, adistal end portion 108, alongitudinal axis 110, anouter surface 112, a firstinner surface 114, a secondinner surface 115, afirst lumen 116, and asecond lumen 118. Thedistal end portion 108 of thetubular sheath body 102 includes atapered surface 103, afirst outlet 105 in fluid communication with thefirst lumen 116, and asecond outlet 107 in fluid communication with thesecond lumen 118. Thetapered surface 103 has an outer diameter graduated from 11 Fr to 15 Fr (3.667 mm to 5 mm). The graduation in the taperedsurface 103 may permit the sheath to be inserted to a variable depth as necessary to plug the gap between the percutaneous pump and the insertion site. - The
outer surface 112 of thetubular sheath body 102 may be coated with a hydrophilic coating to ease insertion of thetubular sheath body 102 into the arteriotomy. A hydrophilic coating can also prevent adhesions to the blood vessel wall. Such adhesions could damage the vessel if the sheath is removed after having been in the blood vessel for an extended period of time (e.g., many days). The risk of adhesion to the blood vessel wall can increase as the duration of a procedure increases. In some embodiments, theouter surface 112 of thetubular sheath body 102 includes depth markings. The depth markings may be pad printed or laser etched onto theouter surface 112. In certain implementations, the depth markings are radio-opaque. The depth markings may be in centimeters, inches, millimeters, or any other suitable unit of measurement or combination thereof. - The first
inner surface 114 of the tubular sheath body defines thefirst lumen 116. Thefirst lumen 116 is dimensioned to allow passage of a portion of the percutaneous pump. Thefirst lumen 116 extends from theproximal end portion 106 of thetubular sheath body 102 to thedistal end portion 108, substantially parallel to thelongitudinal axis 110. Thesecond lumen 118 is disposed within thewall 104 between theinner surface 114 and theouter surface 112. Thesecond lumen 118 extends from theproximal end portion 106 of thetubular sheath body 102 to thedistal end portion 108, offset from and substantially parallel to thelongitudinal axis 110. Thesecond lumen 118 is dimensioned for the passage of a guidewire and is defined by the second inner surface 115 (as shown inFIG. 3 ). The secondinner surface 115 may include a drug or non-drug coating to prevent blood clot formation in thesecond lumen 118. In some implementations, the second inner surface is coated with heparin. Thesecond lumen 118 terminates at thesecond outlet 102 formed in the taperedsurface 103. Thesecond outlet 102 is adjacent to thefirst outlet 105 of thefirst lumen 116. As a result, if a guidewire is inserted through thesecond lumen 118, the guidewire enters the insertion path of the percutaneous pump (not shown) passing through thefirst lumen 116. Thus, thesecond lumen 118 may be used to maintain or regain guidewire access to the insertion path of a percutaneous pump inserted through thefirst lumen 116. This allows guidewire access to the insertion path to be maintained even after an introducer sheath is removed. The guidewire access allows one or more other tools to be subsequently inserted into the same insertion path to facilitate vessel closure or any other medical procedures involving guidewire access. For example, the guidewire access may permit the subsequent insertion of a vessel closure tool or a micro pressure measurement catheter (e.g., MILLAR Mikro-Tip® pressure catheter). A micro pressure measurement catheter may allow measurement of pressure in the left ventricle or any other suitable pressure. Furthermore, since the second lumen enables a physician to maintain guidewire access after the introducer sheath is removed, the physician can remove the introducer sheath earlier. Earlier removal of the introducer sheath allows the vessel aperture to recoil to a smaller diameter, thereby reducing the risk of bleeding through the access site. Additionally, since thesecond outlet 107 is offset from thelongitudinal axis 110, rotating thetubular sheath body 102 allows the position of thesecond outlet 107 to be adjusted. This can allow a user to keep thesecond outlet 107 off of a blood vessel wall to ease insertion of a guidewire or to increase the accuracy of an arterial pressure measurement. - The
tubular sheath body 102 is connected at itsproximal end portion 106 to thehub 126. Thehub 126 includes afirst port 128, asecond port 130, second port threads 131, and abearing 136. Thesecond port 130 is connected to thesecond lumen 118 so that a guidewire can be inserted through thesecond port 130 into thesecond lumen 118 and out of thesecond outlet 107. When a guidewire is not in thesecond lumen 118, thestylet 120 can be inserted into thesecond port 130 to seal the second lumen 118 (as shown inFIGS. 1, 2, and 3 ). Thestylet 120 includes ahead 121, astylet body 122, arounded end 123, andthreads 126. Thestylet body 122 is sized to substantially occlude thesecond lumen 118 when thestylet 120 is inserted into thesecond lumen 118. In some implementations, thestylet body 122 is made of a formable or ductile material, such as a metal. This may allow the stylet to be formed, either during the medical procedure or before, into a shape that reduces stress on the vessel aperture. In certain implementations, thestylet 120 is radio-opaque or includes radio-opaque marker bands to show the depth of thetubular sheath body 102 in a blood vessel. Thethreads 124 of thestylet head 121 reversibly couple with the second port threads 131 to hold thestylet 120 within thesecond lumen 118. When thestylet head 121 is reversibly coupled to thesecond port 130, thestylet head 121 forms a liquid tight seal across thesecond port 130, which prevents the leakage of blood out of the blood vessel. In certain implementations, in place of thestylet 120, a pressure bag is connected to thesecond port 130 using the threads 131. The pressure bag can be used to flush thesecond lumen 118 with a fluid to maintain the patency of thesecond lumen 118. An infusion pump may be used in combination with the pressure bag to regulate the flow rate of liquid into the patient. For example, the flow rate may be limited to 1 mL/hr, 2 mL/hr, 5 mL/hr, 10 mL/hr, or any other suitable flow rate. In some implementations, a pressure measuring device is connected to thesecond port 130 to measure pressure within thevessel 10. This pressure measurement can be used to determine when thesecond port 102 has been inserted sufficiently deep into the blood vessel aperture. For example, when a pressure about equal to arterial pressure is measured at thesecond port 130, thesecond outlet 107 may be in fluid communication with the blood vessel. The pressure measurement can also be used to monitor arterial pressure in the patient's blood vessel during a medical procedure. This may allow an arterial pressure measurement to be taken without the use of an additional catheter, which may reduce the amount of equipment necessary in the potentially crowded operating area. - The
first port 128 of thehub 126 allows the passage of the percutaneous pump (not shown). Thefirst port 128 includes acap 132 and aseal 134. Thecap 132 snaps into thefirst port 128 to hold theseal 134 against thefirst port 128. Thecap 132 and seal 134 together act as a hemostatic valve and form a liquid tight seal between the percutaneous pump and thefirst port 128. Theseal 134 is formed of an elastomer, such as silicone, so that it can flex to seal around a portion of the percutaneous pump. - The
hub 126 is coupled to the stabilizingstructure 150 by thebearing 136. The stabilizingstructure 150 includeswings bearing surface 164 that mates with thebearing 136. The mating of the bearingsurface 164 of the stabilizingstructure 150 with the bearing 136 of thehub 126 allows rotation of thehub 126 relative to the stabilizingstructure 150. As discussed above, this rotation allows thetubular sheath body 102 to be rotated such that thesecond outlet 107 is oriented away from a vessel wall. Additionally, this rotation allows thesecond port 130 to lie flat against a patient when thesecond port 130 is not in use. The suture holes 156-159 allow thewings sheath assembly 100. While only four suture holes 156-159 are shown, any suitable number of suture holes may be used. The stabilizingstructure 150 is also designed to be easily attached to a vascular graft with umbilical tape or sutures. This feature is beneficial during axillary insertions or any other insertions which require pump placement through a vascular graft. Additionally, in some implementations, the stabilizingstructure 150 is coupled to a patient using ribs 160-162. For example, sutures may be wrapped around theouter surface 165 of the stabilizing structure between the ribs 160-162. When sutures are wrapped around theouter surface 165 in such a manner, the ribs 160-162 prevent the sutures from sliding off of theouter surface 165 along thelongitudinal axis 110. In certain implementations, other stabilizations devices, such as surgical tape, a STATLOCK®. stabilization device (Bard Access Systems, Inc., Salt Lake City, Utah), or any other suitable adhesive stabilization device, may be coupled to the stabilizingstructure 150 around the ribs 160-162. -
FIG. 4 shows a detailed section view of thedistal portion 108 of the duallumen sheath assembly 100 ofFIGS. 1, 2, and 3 . Thedistal portion 108 includes the taperedsurface 103, thefirst outlet 105, thesecond outlet 107, and distal portions of thestylet body 122, thefirst lumen 116, and thesecond lumen 118. Thefirst lumen 116 includes aproximal section 116 a having aninner diameter 117, adistal section 116 b having aninner diameter 217 which is less than theinner diameter 117, and arestriction 216 therebetween. Theinner diameter 117 is about 13 Fr (4.333 mm), and theinner diameter 217 is about 9 Fr (3 mm). Therestriction 216 allows thedistal section 116 b of thefirst lumen 116 to form a tighter fit with the percutaneous pump to prevent or reduce blood leakage without causing unacceptably high friction in theproximal section 116 a. Similar to thefirst lumen 116, thesecond lumen 118 includes a proximal section 118 a having adiameter 119, adistal section 118 b having adiameter 219 that is less than thediameter 119, and arestriction 218 therebetween. Thediameter 119 is about 1.1 mm and thediameter 219 is about 1 mm. Therestriction 218 allows a tighter fit between thestylet body 122 and thesecond lumen 118 at the distal section 118 a to reduce blood ingress, while allowing a clearance in theproximal section 118 b to reduce friction. The friction between thesecond lumen 118 and thestylet body 122 is further reduced by the rounding of theend 123 of thestylet body 122. Therounded end 123 is located adjacent to thesecond outlet 107 when thestylet 120 is fully inserted into thesecond lumen 118, thereby preventing or reducing blood ingress into thesecond lumen 118. -
FIG. 5 shows the duallumen sheath assembly 100 ofFIG. 1 inserted into ablood vessel 10 of a patient over apercutaneous pump 60. Thepercutaneous pump 60 includes apump head 66 and acatheter body 62. Thepercutaneous pump 60 may be an intravascular blood pump, a blood pump driven by flexible drive shaft, a blood pump including an implantable motor, a blood pump having an expandable pump rotor, or any other suitable pump. The duallumen sheath assembly 100 is advanced into theblood vessel 10 over thecatheter body 62 of thepercutaneous pump 60 through theblood vessel aperture 12 in the direction indicated byarrow 70. Thefirst lumen 116 of the duallumen sheath assembly 100 may be threaded on thecatheter body 62 when thepercutaneous pump 60 is initially inserted into theblood vessel 10. Theblood vessel 10 may be a femoral artery, and theblood vessel aperture 12 may be an arteriotomy. Theblood vessel aperture 12 may have an opening slightly larger than thediameter 64 of thecatheter body 62. Thus, thetubular body 102 of the duallumen sheath assembly 100 may effectively plug the gap between theblood vessel aperture 12 and the catheter by 64 when thesheath assembly 100 is advanced into theblood vessel 10 over thecatheter body 62. Theouter diameter 101 of thetubular sheath body 102 may be graduated as discussed above to so that thediameter 101 of thetubular sheath body 102 increases from itsdistal end portion 108 to itsproximal end portion 106. This can allow thetubular sheath body 102 to be inserted farther into theblood vessel 100 to plug a larger gap between theblood vessel aperture 12 and thecatheter body 62. The plugging effect of thetubular sheath body 102 can reduce or prevent bleeding out of theblood vessel aperture 12. Thetubular sheath body 102 is flexible so that thetubular sheath body 102 can form abend 80 which allows thetubular sheath body 102 to follow the contours of thevessel 10. This flexibility can reduce the stress placed on theblood vessel aperture 12 by reducing the force required to deform thetubular sheath body 102. - Once the
tubular sheath body 102 has been advanced over thecatheter body 62 of thepercutaneous pump 60 to a sufficient depth to plug the gap between thevessel aperture 12 and thecatheter body 62, the duallumen sheath assembly 100 may be fixed relative to thecatheter body 62. This fixation may be achieved by fixing the stabilizingstructure 150 to the patient'stissue 14. In some implementations, this is achieved by suturing wings (not shown) of the stabilizingstructure 150 to thepatient tissue 14. In certain implementations, the stabilizingstructure 150 is attached to a vascular graft with umbilical tape or sutures. This may be performed during axillary insertions or any other insertions which require pump placement through a vascular graft. In some implementations, fixing the placement of the duallumen sheath assembly 100 may be achieved by tightening theseal 134 around thecatheter body 62 or by means of a separate anchoring ring. Thesecond port 130 may be rotated relative to the stabilizingstructure 150 so that thesecond port 130 lies flat against thepatient tissue 14. After the duallumen sheath assembly 100 has been fixed in the appropriate position, a physician may begin operation of thepercutaneous pump 60. Thepercutaneous pump 60 may be operated during a percutaneous coronary intervention (PCI), open-heart surgery, heart valve replacement surgery, or during treatment of acute myocardial infarction (AMI), cardiogenic shock, or ST segment elevation myocardial infarction (STEMI), as well as any other suitable medical procedure. In certain implementations, thepercutaneous pump 60 is operated for an extended period of time, such as greater than six hours, greater than 12 hours, greater than 24 hours, greater than 48 hours, greater than 72 hours, greater than one week, or any other suitable duration of time. In such cases, a stylet (not shown inFIG. 5 ), such as thestylet 120 fromFIGS. 1-4 , may be positioned within thesecond lumen 118 during insertion of the duallumen sheath assembly 100 to prevent blood ingress into thesecond lumen 118, which could lead to clotting that could obstruct thesecond lumen 118 or to bleeding out of thesecond port 130. - In certain implementations, a pressure bag is connected to the
second port 130 in place of the stylet to maintain the patency of thesecond lumen 118. An infusion pump may be used in combination with the pressure bag to regulate the flow rate of liquid into the patient. For example, the flow rate may be limited to 1 mL/hr, 2 mL/hr, 5 mL/hr, 10 mL/hr, or any other suitable flow rate. In some implementations, a pressure measuring device is connected to thesecond port 130 to measure the pressure within thevessel 10. This pressure measurement can be used to determine when thesecond port 102 has been inserted sufficiently deep into theblood vessel aperture 12. For example, when a pressure about equal to arterial pressure is measured at thesecond port 130, thesecond outlet 107 may be in fluid communication with theblood vessel 10. After penetration into theblood vessel aperture 12 has been detected, the depth of theblood vessel aperture 12 relative to the patient's skin can be measured using depth markings disposed on an outer surface of the sheath. The measurement of this depth can facilitate the subsequent use of certain vessel closure tools which may require such a measurement. The pressure measurement can also be used to monitor arterial pressure in theblood vessel 10 during a medical procedure. This may allow an arterial pressure measurement to be taken without the use of an additional catheter, which may reduce the amount of equipment necessary in the potentially crowded operating area. Additionally, thesecond lumen 118 can allow a determination of the depth of insertion without a pressure transducer by allowing observation of the onset of blood flow through the second lumen 118 (“bleedback”), which is indicative of penetration into theblood vessel aperture 12. - When it is time to remove the
percutaneous pump 60, aguidewire 50 is inserted through thesecond port 130 into thesecond lumen 118 and out thesecond outlet 107 into theblood vessel 10. Thus, theguidewire 50 enters the same insertion path as thepercutaneous pump 60, thereby maintaining access to the insertion path. If a stylet was used during insertion of the duallumen sheath assembly 100, the stylet is removed before insertion of theguidewire 50. Theguidewire 50 has an outer diameter that approximately matches the inner diameter of thesecond outlet 107 to prevent blood from flowing out of theblood vessel 10 through thesecond port 130. For example, the guidewire may have an outer diameter of about 1 mm. Additionally, in some implementations, a seal at thesecond port 130 is included to further ensure that no blood exits thesecond port 130 while theguidewire 50 is in place. - After the
guidewire 50 has been placed in theblood vessel 10, thepercutaneous pump 60 and the duallumen sheath assembly 100 may be removed through theblood vessel aperture 12 while theguidewire 50 is left in place. Thetubular sheath body 102 may be coated with a hydrophilic coating or any other suitable coating that prevents adhesions to theblood vessel 10, thereby facilitating removal of thetubular sheath body 102 without damaging theblood vessel 10. The removal of the duallumen sheath assembly 100 andpercutaneous pump 60 while theguidewire 50 is left in place allows guidewire access to theinsertion path 11 to be maintained. The removal of thepercutaneous pump 60 requires the concurrent removal of the duallumen sheath assembly 100 because thediameter 68 of thepump head 66 cannot pass through thefirst lumen 116. This is because the inner diameter of thefirst lumen 116 is sized to fit tightly around thediameter 64 of thecatheter body 62, but cannot accommodate thelarger diameter 68 of thepump head 66. As a result, thefirst lumen 116 is not available to be used to maintain guidewire access to theinsertion path 11. Thus, thesecond lumen 118 is necessary to maintain guidewire access to theinsertion path 11. - After the
percutaneous pump 60 and the duallumen sheath assembly 100 have been removed, theguidewire 50 remains in theblood vessel 10 and theinsertion path 11. Thus, another tool may be inserted over theguidewire 50 into theinsertion path 11. In some implementations, a vascular closure device is inserted into theinsertion path 11 using theguidewire 50. The vascular closure device may be the VASOSEAL vascular sealing device, the ANGIO-SEAL bio-absorbable active closure system, the PERCLOSE vascular sealing device, or any other suitable vascular closure device or combination of vascular closure devices. After a vascular closure device or other device has been successfully inserted through thevessel aperture 12 into theinsertion path 11, theguidewire 50 may be removed from thevessel aperture 12. -
FIG. 6 shows anillustrative process 600 for maintaining guidewire access. Theillustrative process 600 may be performed using the duallumen sheath assembly 100 or any other suitable sheath tool. Instep 602, a sheath is inserted into a blood vessel through a percutaneous insertion path and along a portion of a percutaneous pump. The sheath has a first lumen and a second lumen. The blood vessel may be an artery, such as the femoral artery. The insertion path passes through a blood vessel aperture (e.g., an arteriotomy). The percutaneous pump is inserted into the insertion path using an introducer prior to step 602. Therefore, the percutaneous pump guides the sheath into the existing insertion path. The percutaneous pump may be an intravascular blood pump, a blood pump driven by flexible drive shaft, a blood pump including an implantable motor, a blood pump having an expandable pump rotor, or any other suitable pump. The first lumen of the sheath may be sealed against the percutaneous pump by a hemostatic valve to prevent leakage of blood from the blood vessel out of the patient. - In some implementations, the sheath is only inserted into the vessel as deep as is necessary to close the gap between the percutaneous pump and the vessel aperture to prevent bleeding. To reliably detect whether the sheath has been inserted sufficiently deep into the vessel, the pressure within the vessel can be detected using the second lumen. For example, a detected pressure about equal to arterial pressure may indicate that the outlet of the second lumen has been inserted into the blood vessel. Alternatively, the second lumen can allow a determination of the depth of insertion without a pressure transducer by allowing observation of the onset of blood flow through the second lumen (“bleedback”), which is indicative of penetration into the blood vessel aperture. After penetration into the blood vessel aperture has been detected, the depth of the blood vessel aperture relative to the patient's skin can be measured using depth markings disposed on an outer surface of the sheath. In some implementations, the depth markings are radio-opaque and can be imaged using a tomographic imaging modality (e.g., CT, MRI, X-ray). The measurement of this depth can facilitate the subsequent use of certain vessel closure tools which may require such a measurement. Additionally, once inserted to the appropriate depth, the second lumen can be used to measure arterial pressure during the procedure.
- In
step 604, the sheath is maintained in the vessel for about six hours or more while blood clot formation is prevented from occluding the second lumen. The sheath may be maintained in the vessel for 6 hours, 12 hours, 24 hours, 48 hours, 72 hours, one week, two weeks, or any other suitable duration of time. Blood clot formation in the second lumen may be prevented during this time using a stylet that temporarily occludes the second lumen. For example, thestylet 120 ofFIGS. 1-3 may be used to temporarily occlude the second lumen. In certain implementations, blood clot formation in the second lumen is prevented or reduced using a drug or nondrug coating in the second lumen. The coating may include heparin or any other suitable substance. In some implementations, blood clot formation in the second lumen is prevented or reduced by flushing the second lumen with a liquid (e.g., saline solution, glucose solution, or any other suitable solution). Preventing the occlusion of the second lumen by blood clots allows the patency of the second lumen to be preserved for insertion of a guidewire. - In
step 606, a guidewire is inserted through the second lumen into the percutaneous insertion path after the about six hours or more. If a stylet was used to temporarily occlude the second lumen, the stylet is removed before inserting the guidewire. The percutaneous pump inserted through the first lumen may be removed after insertion of the guidewire. After the guidewire has been inserted, the sheath may be removed from the percutaneous insertion path while the guidewire remains in place. This can allow another tool (e.g., an access closure tool) to be inserted into the insertion path. This frees a physician from depending on an introducer to maintain guidewire access. Thus, the physician is able to remove the introducer earlier in a procedure. This can allow greater recoil of the blood vessel aperture, thereby reducing the risk of bleeding. For example, removing the introducer within an hour of insertion may allow a recoil of about 2 to 3 Fr (0.667 mm to 1 mm). - The foregoing is merely illustrative of the principles of the disclosure, and the systems, methods, and devices can be practiced by other than the described embodiments, which are presented for purposes of illustration and not of limitation. It is to be understood that the systems, methods, and devices disclosed herein, while shown for use in a system percutaneous intravascular blood pumps, may be applied to systems, methods, and devices for other implantable blood pumps or implantable cardiac assist devices.
- Variations and modifications will occur to those of skill in the art after reviewing this disclosure. For example, in some implementations, the sheath assembly may be used to provide guidewire access for procedures of a short duration (e.g., less than six hours). Furthermore, the stylet may be omitted in some implementations in which the patency of the second lumen is adequately maintained by other means. For example, in some implementations, the second lumen is flushed with a liquid, either intermittently or continuously. The disclosed features may be implemented, in any combination and subcombination (including multiple dependent combinations and subcombinations), with one or more other features described herein. The various features described or illustrated above, including any components thereof, may be combined or integrated in other systems. Moreover, certain features may be omitted or not implemented.
- Examples of changes, substitutions, and alterations are ascertainable by one skilled in the art and could be made without departing from the scope of the information disclosed herein. All references cited herein are incorporated by reference in their entirety and made part of this application.
Claims (10)
1.-15. (canceled)
16. A method for maintaining guidewire access comprising:
inserting a sheath into a blood vessel through a percutaneous insertion path and along a portion of a percutaneous pump, wherein the sheath has a first lumen and a second lumen;
maintaining the sheath in the blood vessel for more than 6 hours while preventing blood clot formation from occluding the second lumen; and
inserting a guidewire through the second lumen into the percutaneous insertion path after the more than 6 hours.
17. The method of claim 16 , wherein the preventing blood clot formation from occluding the second lumen comprises inserting a stylet into the second lumen for more than 6 hours, and removing the stylet before inserting the guidewire.
18. The method of claim 16 , wherein the preventing blood clot formation from occluding the second lumen comprises flushing the second lumen with purge fluid.
19. The method of claim 16 , further comprising removing the sheath while maintaining the guidewire in the percutaneous insertion path.
20. The method of claim 19 , further comprising inserting a percutaneous tool over the guidewire into the percutaneous insertion path after the sheath is removed.
21. The method of claim 19 , wherein the second lumen having a proximal inlet and a distal outlet, and wherein the method further comprising:
coupling a sensor to the proximal inlet of the second lumen; and
transducing arterial pressure at the distal outlet of the second lumen using the sensor.
22. The method of claim 21 , wherein the method further comprises rotating the sheath relative to a support structure when an arterial pressure measurement indicates that the distal outlet of the second lumen is occluded by an arterial wall.
23. The method of claim 22 , further comprising determining a depth of insertion from the arterial pressure measurement.
24. The method of claim 23 , wherein the depth of insertion is determined based on markings disposed on an outer surface of the sheath.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/907,533 US20200324034A1 (en) | 2015-08-17 | 2020-06-22 | Dual lumen sheath for arterial access |
US17/351,671 US11833314B2 (en) | 2015-08-17 | 2021-06-18 | Dual lumen sheath for arterial access |
US18/381,219 US20240189546A1 (en) | 2015-08-17 | 2023-10-18 | Dual lumen sheath for arterial access |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/827,741 US10737008B2 (en) | 2015-08-17 | 2015-08-17 | Dual lumen sheath for arterial access |
US16/907,533 US20200324034A1 (en) | 2015-08-17 | 2020-06-22 | Dual lumen sheath for arterial access |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/827,741 Division US10737008B2 (en) | 2015-08-17 | 2015-08-17 | Dual lumen sheath for arterial access |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/351,671 Continuation US11833314B2 (en) | 2015-08-17 | 2021-06-18 | Dual lumen sheath for arterial access |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200324034A1 true US20200324034A1 (en) | 2020-10-15 |
Family
ID=58051709
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/827,741 Active US10737008B2 (en) | 2015-08-17 | 2015-08-17 | Dual lumen sheath for arterial access |
US16/907,533 Abandoned US20200324034A1 (en) | 2015-08-17 | 2020-06-22 | Dual lumen sheath for arterial access |
US17/351,671 Active 2035-10-26 US11833314B2 (en) | 2015-08-17 | 2021-06-18 | Dual lumen sheath for arterial access |
US18/381,219 Pending US20240189546A1 (en) | 2015-08-17 | 2023-10-18 | Dual lumen sheath for arterial access |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/827,741 Active US10737008B2 (en) | 2015-08-17 | 2015-08-17 | Dual lumen sheath for arterial access |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/351,671 Active 2035-10-26 US11833314B2 (en) | 2015-08-17 | 2021-06-18 | Dual lumen sheath for arterial access |
US18/381,219 Pending US20240189546A1 (en) | 2015-08-17 | 2023-10-18 | Dual lumen sheath for arterial access |
Country Status (12)
Country | Link |
---|---|
US (4) | US10737008B2 (en) |
EP (2) | EP4032577A1 (en) |
JP (4) | JP6851114B2 (en) |
KR (4) | KR102582830B1 (en) |
CN (1) | CN210698360U (en) |
AU (3) | AU2016308193B2 (en) |
BR (1) | BR112018003164B1 (en) |
CA (2) | CA2995707C (en) |
DK (1) | DK3337530T3 (en) |
ES (1) | ES2909848T3 (en) |
IL (6) | IL296370B2 (en) |
WO (1) | WO2017031243A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3066361A1 (en) | 2017-06-07 | 2018-12-13 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
KR20240005145A (en) * | 2017-06-28 | 2024-01-11 | 아비오메드, 인크. | Guidewire access sleeve |
EP3681553A2 (en) * | 2017-09-14 | 2020-07-22 | Abiomed, Inc. | Integrated expandable access for medical device introducer |
US11511103B2 (en) | 2017-11-13 | 2022-11-29 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
DE102018201030A1 (en) | 2018-01-24 | 2019-07-25 | Kardion Gmbh | Magnetic coupling element with magnetic bearing function |
CN112004563B (en) | 2018-02-01 | 2024-08-06 | 施菲姆德控股有限责任公司 | Intravascular blood pump and methods of use and manufacture |
EP3758781B1 (en) * | 2018-02-26 | 2021-03-31 | CTI Vascular AG | Usable-length-selectable catheter to treat vascular pathologies |
US11167121B2 (en) * | 2018-05-15 | 2021-11-09 | Cardiovascular Systems, Inc. | Intravascular pump with integrated isolated conductor(s) and methods thereof |
DE102018207611A1 (en) | 2018-05-16 | 2019-11-21 | Kardion Gmbh | Rotor bearing system |
DE102018208541A1 (en) | 2018-05-30 | 2019-12-05 | Kardion Gmbh | Axial pump for a cardiac assist system and method of making an axial pump for a cardiac assist system |
DE102018211327A1 (en) | 2018-07-10 | 2020-01-16 | Kardion Gmbh | Impeller for an implantable vascular support system |
DE102018212153A1 (en) | 2018-07-20 | 2020-01-23 | Kardion Gmbh | Inlet line for a pump unit of a cardiac support system, cardiac support system and method for producing an inlet line for a pump unit of a cardiac support system |
DK3866876T3 (en) * | 2018-10-18 | 2022-12-19 | Abiomed Inc | SYSTEMS TO MINIMIZE LEAKS DURING INSERTION OF PUMPS |
US11497894B2 (en) * | 2018-12-21 | 2022-11-15 | Abiomed, Inc. | Persistent perfusion sheath |
US12042170B2 (en) | 2019-05-12 | 2024-07-23 | EvolutionMedVentures LLC | Add-on sheath |
WO2021011473A1 (en) | 2019-07-12 | 2021-01-21 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of manufacture and use |
WO2021016372A1 (en) | 2019-07-22 | 2021-01-28 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
US11724089B2 (en) | 2019-09-25 | 2023-08-15 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
DE102020102474A1 (en) | 2020-01-31 | 2021-08-05 | Kardion Gmbh | Pump for conveying a fluid and method for manufacturing a pump |
EP3861946B1 (en) * | 2020-05-28 | 2022-06-08 | Medinice S.A. | Cannula for percutaneous minimally invasive cannulation of the vena cava |
JP6851533B1 (en) * | 2020-06-10 | 2021-03-31 | ガデリウス・メディカル株式会社 | Contrast injection catheter |
WO2022103932A1 (en) | 2020-11-15 | 2022-05-19 | EvolutionMedVentures LLC | Sheath stepwise dilation |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4137916A (en) | 1976-11-22 | 1979-02-06 | Travenol Laboratories, Inc. | Catheter plug assembly |
US4180068A (en) | 1978-04-13 | 1979-12-25 | Motion Control, Incorporated | Bi-directional flow catheter with retractable trocar/valve structure |
US4643711A (en) * | 1984-05-25 | 1987-02-17 | Cook, Inc. | Two lumen hemodialysis catheter |
JPS61199867A (en) * | 1985-02-28 | 1986-09-04 | バイオメデイカル株式会社 | Stay catheter in blood vessel |
US4699611A (en) | 1985-04-19 | 1987-10-13 | C. R. Bard, Inc. | Biliary stent introducer |
US4995863A (en) | 1986-10-06 | 1991-02-26 | Catheter Technology Corporation | Catheter with slit valve |
DE3831464A1 (en) | 1988-09-16 | 1990-03-29 | Hoechst Ag | METHOD FOR ALKALI-FREE DYEING AND PRINTING OF CELLULOSE FIBERS |
US5234425A (en) | 1989-03-03 | 1993-08-10 | Thomas J. Fogarty | Variable diameter sheath method and apparatus for use in body passages |
US5273527A (en) * | 1992-05-12 | 1993-12-28 | Ovamed Corporation | Delivery catheter |
US5139486A (en) | 1991-01-02 | 1992-08-18 | Gerald Moss | Dilator/introducer for percutaneous gastrostomy |
WO1993006878A1 (en) | 1991-10-11 | 1993-04-15 | Boston Scientific Corporation | Catheter introducer sheath assembly |
US5935122A (en) | 1991-12-13 | 1999-08-10 | Endovascular Technologies, Inc. | Dual valve, flexible expandable sheath and method |
US5395349A (en) | 1991-12-13 | 1995-03-07 | Endovascular Technologies, Inc. | Dual valve reinforced sheath and method |
US5304142A (en) | 1992-08-04 | 1994-04-19 | Medamicus, Inc. | Dilator - Introducer locking hub and sheath valve apparatus |
US5320611A (en) | 1993-02-04 | 1994-06-14 | Peter M. Bonutti | Expandable cannula having longitudinal wire and method of use |
US6338730B1 (en) | 1993-02-04 | 2002-01-15 | Peter M. Bonutti | Method of using expandable cannula |
US5431639A (en) * | 1993-08-12 | 1995-07-11 | Boston Scientific Corporation | Treating wounds caused by medical procedures |
US5492530A (en) | 1994-02-07 | 1996-02-20 | Cathco, Inc. | Method for accessing the coronary arteries from the radial or brachial artery in the arm |
US5407430A (en) | 1994-03-21 | 1995-04-18 | Peters; Michael J. | Intravenous catheter |
US5395341A (en) | 1994-03-21 | 1995-03-07 | Cordis Corporation | One piece vessel dilator/catheter sheath introducer |
US5488960A (en) | 1994-04-11 | 1996-02-06 | Abbott Laboratories | Coronary sinus catheter introducer system |
US5536255A (en) | 1994-10-03 | 1996-07-16 | Moss; Gerald | Dilator/introducer apparatus for percutaneous gastrostomy |
US5971993A (en) | 1996-11-07 | 1999-10-26 | Myocardial Stents, Inc. | System for delivery of a trans myocardial device to a heart wall |
US5911702A (en) | 1997-11-06 | 1999-06-15 | Heartport, Inc. | Methods and devices for cannulating a patient's blood vessel |
US6692462B2 (en) | 1999-05-19 | 2004-02-17 | Mackenzie Andrew J. | System and method for establishing vascular access |
US6607547B1 (en) | 1999-08-25 | 2003-08-19 | Origin Medsystems, Inc. | Longitudinal dilator and method |
US20060287574A1 (en) | 1999-08-25 | 2006-12-21 | Chin Albert K | Longitudinal dilator |
WO2001017581A2 (en) * | 1999-09-03 | 2001-03-15 | A-Med Systems, Inc. | Guidable intravascular blood pump and related methods |
US6858019B2 (en) * | 2001-01-09 | 2005-02-22 | Rex Medical, L.P. | Dialysis catheter and methods of insertion |
CN100525850C (en) | 2001-12-26 | 2009-08-12 | 耶鲁大学 | Vascular access device |
JP3942465B2 (en) * | 2002-03-22 | 2007-07-11 | 住友ベークライト株式会社 | Indwelling catheter |
US8509916B2 (en) | 2002-12-16 | 2013-08-13 | Medtronic, Inc. | Bilumen guide catheters for accessing cardiac sites |
US7037290B2 (en) | 2002-12-16 | 2006-05-02 | Medtronic, Inc. | Multi-lumen steerable catheter |
WO2005032642A2 (en) | 2003-10-03 | 2005-04-14 | Acumen Medical, Inc. | Expandable guide sheath and apparatus and methods for making them |
JP2005287670A (en) * | 2004-03-31 | 2005-10-20 | Nipro Corp | Blood vessel indwelling catheter |
US20060135981A1 (en) | 2004-09-09 | 2006-06-22 | Jay Lenker | Expandable transluminal sheath |
WO2006074044A2 (en) | 2004-12-30 | 2006-07-13 | Neomend, Inc. | Method and apparatus for percutaneous wound sealing |
ATE535279T1 (en) | 2005-07-19 | 2011-12-15 | Shalom Zvi Ben | ORGAN SUPPORT SYSTEM |
JP5111767B2 (en) * | 2006-02-03 | 2013-01-09 | ユニチカ株式会社 | Triple lumen catheter |
ATE531417T1 (en) * | 2006-04-21 | 2011-11-15 | Abbott Lab | GUIDE WIRE POSITIONING DEVICE |
US20080051821A1 (en) | 2006-08-22 | 2008-02-28 | Gephart Matthew P | Tissue dilation tool and method of dilating tissue |
CN101662999B (en) | 2006-09-28 | 2016-01-20 | 心叶科技公司 | For the means of delivery of percutaneous conveying prosthese |
US8317773B2 (en) | 2006-11-07 | 2012-11-27 | Angio Dynamics, Inc. | Catheter with open faced sloped end portion |
US8292841B2 (en) | 2007-10-26 | 2012-10-23 | C. R. Bard, Inc. | Solid-body catheter including lateral distal openings |
US20090240202A1 (en) | 2008-03-21 | 2009-09-24 | William Joseph Drasler | Expandable introducer sheath |
US8231519B2 (en) * | 2009-05-20 | 2012-07-31 | Thoratec Corporation | Multi-lumen cannula |
CN102481398A (en) | 2009-07-01 | 2012-05-30 | 宾夕法尼亚州研究基金会 | Blood pump with expandable cannula |
US20110040241A1 (en) | 2009-08-11 | 2011-02-17 | Dongfang Wang | Blood access assembly for artificial lung and right ventricular assist device |
US8562519B2 (en) * | 2009-12-31 | 2013-10-22 | Cardiacassist, Inc. | Pumping system and method for assisting a patient's heart |
US20110319728A1 (en) | 2010-06-29 | 2011-12-29 | Edwards Lifesciences Corporation | Blood parameter sensor and flow control system, method and computer program product |
US9180274B2 (en) * | 2010-09-09 | 2015-11-10 | W. L. G ore & Associates, Inc | Indwelling luminal devices |
US8758402B2 (en) | 2010-12-17 | 2014-06-24 | Boston Scientific Scimed, Inc. | Tissue puncture closure device |
US20170112480A9 (en) | 2010-12-17 | 2017-04-27 | Boston Scientific Scimed, Inc. | Expandable device sheath for vascular closure plug deployment |
JP5936093B2 (en) * | 2011-05-02 | 2016-06-15 | ニプロ株式会社 | Double lumen dilator |
JP2012249732A (en) | 2011-06-01 | 2012-12-20 | Univ Of Tokyo | Cannula and assisted circulation device |
US9168352B2 (en) | 2011-12-19 | 2015-10-27 | Cardiacassist, Inc. | Dual lumen cannula |
EP2606920A1 (en) * | 2011-12-22 | 2013-06-26 | ECP Entwicklungsgesellschaft mbH | Sluice device for inserting a catheter |
US20130317438A1 (en) | 2012-05-25 | 2013-11-28 | Arstasis, Inc. | Vascular access configuration |
US20130317481A1 (en) | 2012-05-25 | 2013-11-28 | Arstasis, Inc. | Vascular access configuration |
US20150051635A1 (en) | 2013-08-14 | 2015-02-19 | Zoll Circulation, Inc. | Aortic occluder with strength bonded balloons |
WO2016011091A1 (en) * | 2014-07-14 | 2016-01-21 | C. R. Bard, Inc. | Apparatuses, systems, and methods for inserting split tip catheters having enhanced stiffening and guiding features |
-
2015
- 2015-08-17 US US14/827,741 patent/US10737008B2/en active Active
-
2016
- 2016-08-17 KR KR1020227010207A patent/KR102582830B1/en active IP Right Grant
- 2016-08-17 CN CN201690001274.5U patent/CN210698360U/en active Active
- 2016-08-17 KR KR1020247020254A patent/KR20240099509A/en active Search and Examination
- 2016-08-17 IL IL296370A patent/IL296370B2/en unknown
- 2016-08-17 IL IL312920A patent/IL312920A/en unknown
- 2016-08-17 WO PCT/US2016/047421 patent/WO2017031243A1/en active Application Filing
- 2016-08-17 JP JP2018508747A patent/JP6851114B2/en active Active
- 2016-08-17 AU AU2016308193A patent/AU2016308193B2/en active Active
- 2016-08-17 IL IL302844A patent/IL302844B2/en unknown
- 2016-08-17 KR KR1020237032316A patent/KR102677705B1/en active IP Right Grant
- 2016-08-17 CA CA2995707A patent/CA2995707C/en active Active
- 2016-08-17 IL IL308629A patent/IL308629B1/en unknown
- 2016-08-17 KR KR1020187007479A patent/KR102381615B1/en active IP Right Grant
- 2016-08-17 DK DK16837779.4T patent/DK3337530T3/en active
- 2016-08-17 BR BR112018003164-0A patent/BR112018003164B1/en active IP Right Grant
- 2016-08-17 CA CA3224423A patent/CA3224423A1/en active Pending
- 2016-08-17 EP EP22161299.7A patent/EP4032577A1/en active Pending
- 2016-08-17 EP EP16837779.4A patent/EP3337530B1/en active Active
- 2016-08-17 ES ES16837779T patent/ES2909848T3/en active Active
-
2018
- 2018-02-15 IL IL257546A patent/IL257546B/en unknown
-
2020
- 2020-06-22 US US16/907,533 patent/US20200324034A1/en not_active Abandoned
-
2021
- 2021-03-04 JP JP2021034186A patent/JP7169386B2/en active Active
- 2021-06-18 US US17/351,671 patent/US11833314B2/en active Active
- 2021-06-30 AU AU2021204533A patent/AU2021204533B2/en active Active
- 2021-08-19 IL IL285740A patent/IL285740B2/en unknown
-
2022
- 2022-10-28 JP JP2022172912A patent/JP7401629B2/en active Active
-
2023
- 2023-10-18 US US18/381,219 patent/US20240189546A1/en active Pending
- 2023-11-28 AU AU2023274093A patent/AU2023274093A1/en active Pending
- 2023-12-07 JP JP2023206608A patent/JP2024028884A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11833314B2 (en) | Dual lumen sheath for arterial access | |
EP2063823B1 (en) | Devices, system, kit and method for epicardial access | |
CA2772598A1 (en) | Coaxial transseptal guide-wire and needle assembly |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ABIOMED, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CORBETT, SCOTT C.;FANTUZZI, GLENN R.;MURPHY, JOHN;AND OTHERS;REEL/FRAME:052999/0350 Effective date: 20151207 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STCB | Information on status: application discontinuation |
Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |